A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation. . . . → Read More: Computer-Designed Heart Valves Operate Over Long Term
|
|||||
 One comment - (Comments are closed)  New products  biomedical, engineering, Europe, heart disease, life sciences, mathematics, medical device, patent, physical sciences, preclinical, software, stem cells, university 
A rehabilitation research foundation and company specializing in immersive technologies are applying virtual reality to help treat spacial neglect, a common cognitive disability associated with stroke. . . . → Read More: Virtual Reality Harnessed for Stroke Rehab Comments are closed Finance, Joint ventures/collaborations biomedical, engineering, Europe, grant, life sciences, medical device, physical sciences, software A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal Comments are closed Finance biomedical, biotechnology, clinical trials, equity, Europe, FDA, genomics, investment, life sciences, merger, pharmaceuticals A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease. . . . → Read More: Drug Shown Able to Kill Malaria-Carrier Mosquitoes One comment - (Comments are closed) New products Africa, biomedical, clinical trials, Europe, health care, life sciences, pharmaceuticals, U.K., university An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe. . . . → Read More: Immune Disease Precision Therapy Company Starts Up One comment - (Comments are closed) Finance, New products biomarkers, biomedical, cancer, entrepreneurs, equity, Europe, investment, life sciences, pharmaceuticals, U.K., university, venture capital Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer. . . . → Read More: Novartis Licenses Biomaterial for Cancer Immunotherapy One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, clinical trials, engineering, Europe, licensing, materials science, pharmaceuticals, physical sciences, university A European initiative is developing a laser-enhanced technology to better distinguish between cancerous and benign thyroid nodules, for catching thyroid cancer earlier as well as preventing unnecessary surgeries. . . . → Read More: More Accurate Thyroid Cancer Screening Technology Advances Comments are closed New products biomedical, cancer, engineering, Europe, life sciences, medical device, physical sciences, physics A company in Finland is beginning a service that allows pathologists and researchers the ability to design their own artificial intelligence algorithms without writing code, for analyzing visual images of tissue samples. . . . → Read More: Self-Service A.I. Offered for Pathologists One comment - (Comments are closed) New products biomedical, Canada, computer science, engineering, entrepreneurs, Europe, life sciences, mathematics, medical device, physical sciences, software, university Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France. . . . → Read More: Evotec Acquiring Sanofi Infectious Disease Portfolio Comments are closed Hiring/layoffs, Intellectual property biomedical, Europe, licensing, life sciences, pharmaceuticals A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital. . . . → Read More: Breathalyzer Biopsy Company Gains $15M in New Funds Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, engineering, entrepreneurs, equity, Europe, investment, life sciences, medical device, physical sciences, U.K., university, venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
